Shoemaker Shannon 4
4 · PSYCHEMEDICS CORP · Filed Sep 25, 2023
Insider Transaction Report
Form 4
Shoemaker Shannon
Chief Revenue Officer
Transactions
- Award
Stock Option (Right to Buy)
2023-09-21+80,000→ 80,000 totalExercise: $3.66Exp: 2033-09-21→ Common Stock, $.005 Par Value (80,000 underlying) - Award
Stock Option (Right to Buy)
2023-09-21+40,000→ 40,000 totalExercise: $3.66Exp: 2033-09-21→ Common Stock, $.005 Par Value (40,000 underlying)
Footnotes (2)
- [F1]The option becomes exercisable with respect to 50% of the shares on September 18, 2024 and with respect to the remaining 50% on September 18, 2025.
- [F2]The option becomes exercisable, if at all, in two 40,000 share increments. The first increment of 40,000 shares becomes exercisable at the time the weighted average daily price of Psychemedics common stock on the Nasdaq Stock Market during any consecutive 60 calendar day period ending on or before September 21, 2026 shall have exceeded $5.50. The second increment of 40,000 shares becomes exercisable at the time the weighted average daily price of Psychemedics common stock on the Nasdaq Stock Market during any consecutive 60 calendar day period ending on or before September 21, 2027 shall have exceeded $6.50.